Pacira BioSciences, Inc. (FRA:82P)

Germany flag Germany · Delayed Price · Currency is EUR
20.60
+0.20 (0.98%)
Last updated: Dec 5, 2025, 3:47 PM CET
27.16%
Market Cap 884.64M
Revenue (ttm) 610.92M
Net Income (ttm) 18.27M
Shares Out n/a
EPS (ttm) 0.40
PE Ratio 48.42
Forward PE 6.63
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 20.20
Previous Close 20.40
Day's Range 20.20 - 20.60
52-Week Range 15.80 - 26.20
Beta n/a
RSI 51.52
Earnings Date Feb 26, 2026

About Pacira BioSciences

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled dos... [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Employees 790
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 82P
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.